Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Hamamoto

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Cancer Chemotherapy and Pharmacology|February 26, 2017
Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapyAkiyoshi Kasuga, Yasuo Hamamoto, Ayano Takeuchi, et al.
Journal of Biomedical Optics|June 11, 2004
Appearance of enhanced tissue features in narrow-band endoscopic imagingKazuhiro Gono, Takashi Obi, Masahiro Yamaguchi, et al.
Japanese Journal of Clinical Oncology|March 17, 2009
A phase 2 clinical trial of panitumumab monotherapy in Japanese patients with metastatic colorectal cancerKei Muro, Takayuki Yoshino, Toshihiko Doi, et al.
BMJ Supportive & Palliative Care|October 15, 2021
Prospective feasibility study of indigo naturalis ointment for chemotherapy-induced oral mucositisKenro Hirata, Yuka Yamada, Yasuo Hamamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2013
[An autopsy case of unresectable colon cancer who developed lung injury by cetuximab]Junko Uemoto, Yasuo Hamamoto, Kei Onodera, et al.
Oncology Letters|December 21, 2012
Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literatureShinsuke Funakoshi, Akinori Hashiguchi, Kana Teramoto, et al.
International Journal of Clinical Oncology|May 9, 2008
Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancerNozomu Fuse, Toshihiko Doi, Atsushi Ohtsu, et al.
International Journal of Colorectal Disease|October 19, 2004
A case of colorectal carcinoma in adenoma analyzed by a cDNA arrayKatsuhiko Nosho, Hiroyuki Yamamoto, Hiroyuki Takamaru, et al.
Cancer Science|June 15, 2013
Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805)Chigusa Morizane, Takuji Okusaka, Junki Mizusawa, et al.
Oncology Letters|September 21, 2017
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case reportKenta Kawasaki, Yasuo Hamamoto, Takeshi Suzuki, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|February 26, 2017
Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapyAkiyoshi Kasuga, Yasuo Hamamoto, Ayano Takeuchi, et al.
Journal of Biomedical Optics|June 11, 2004
Appearance of enhanced tissue features in narrow-band endoscopic imagingKazuhiro Gono, Takashi Obi, Masahiro Yamaguchi, et al.
Japanese Journal of Clinical Oncology|March 17, 2009
A phase 2 clinical trial of panitumumab monotherapy in Japanese patients with metastatic colorectal cancerKei Muro, Takayuki Yoshino, Toshihiko Doi, et al.
BMJ Supportive & Palliative Care|October 15, 2021
Prospective feasibility study of indigo naturalis ointment for chemotherapy-induced oral mucositisKenro Hirata, Yuka Yamada, Yasuo Hamamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2013
[An autopsy case of unresectable colon cancer who developed lung injury by cetuximab]Junko Uemoto, Yasuo Hamamoto, Kei Onodera, et al.
Oncology Letters|December 21, 2012
Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literatureShinsuke Funakoshi, Akinori Hashiguchi, Kana Teramoto, et al.
International Journal of Clinical Oncology|May 9, 2008
Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancerNozomu Fuse, Toshihiko Doi, Atsushi Ohtsu, et al.
International Journal of Colorectal Disease|October 19, 2004
A case of colorectal carcinoma in adenoma analyzed by a cDNA arrayKatsuhiko Nosho, Hiroyuki Yamamoto, Hiroyuki Takamaru, et al.
Cancer Science|June 15, 2013
Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805)Chigusa Morizane, Takuji Okusaka, Junki Mizusawa, et al.
Oncology Letters|September 21, 2017
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case reportKenta Kawasaki, Yasuo Hamamoto, Takeshi Suzuki, et al.
Pageof 13